Lancet Commissionå ±åæžãäžåœã®è²§å°åæžã«ãããä¿å¥å»ççµ±åã¢ãããŒãã¯äžçã®éçºã«ç€ºåãäžãããšææ
 ,å京ã2026幎11æ5æ¥ /PRNewswire/ -- è²§å°ã¯äŸç¶ãšããŠäžçã®éçºã«ãããäž»èŠãªèª²é¡ã§ãã10æ29æ¥ã«æž è¯å€§åŠã§çºè¡šãããLancet Commissionã®å ±åæžã«ãããšãäžåœãè²§å°åæžã«ä¿å¥å»çãåãå ¥ããåãçµã¿ã¯ãè匱ãªäžåž¯ãä¿è·ãå¥åº·ã®å ¬å¹³æ§ã®åäžãç®æãåœã ã«ãšã£ãŠç€ºåãæäŸãããã®ãšãªã£ãŠããŸããÂ
æž è¯å€§åŠãäž»å°ããäžç§å ¬å ±è¡çåŠé¢é·ã§WHOåèªäºåå±é·ã®Margaret Chanæ°ãå§å¡é·ãåããLancet Commissionã¯ãäžåœã®ä¿å¥å»çã«ããè²§å°å¯Ÿçæ¿çããã®å®æœç¶æ³ããªãã³ã«ã°ããŒãã«ãã«ã¹ãžã®åºç¯ãªåœ±é¿ã«é¢ãã4幎éã®ããŒã¿ãåæããŸããã
æ¬å ±åæžã¯ãäžåœãå®å šãªé£²ææ°Žãäœå® ãæ é€ãæè²ãžã®ä»å ¥ãšãšãã«ãçµæžçä¿è·ãšãã©ã€ããªãã«ã¹ã±ã¢ãã©ã®ããã«çµã¿åãããããæ€èšŒããŠããŸãã
äž»ãªèª¿æ»çµæã¯æ¬¡ã®ãšããã§ãã
- 2015幎ãã2020幎ã®éã«ãä¿å¥å»çé¢é£ã®è²§å°å¯Ÿçã«çŽ1å 4,000åå ãæè³ãããŸããã
- åœã®ç£èŠã·ã¹ãã ã«ããã8,000äžäººãè¶ ããäœæåŸã®èŸ²æäœæ°ã远跡調æ»ãããä¿å¥å»çé¢é£ã®è²§å°ãªã¹ã¯ãç¹å®ãããŠããŸãã
- è²§å°å±€ã®äººã ãèªå·±è² æ ããå ¥é¢è²»çšã®å²åã¯ã2013幎ã®41.0%ãã2018幎ã«ã¯31.0%ã«æžå°ããŸããã
è€æ°ã®æ¿çãåæã«å®æœãããŠããããšãããŒã¿ã®å¶çŽãèæ ®ãããšãåã ã®æœçã®è²¢ç®åºŠãè©äŸ¡ããããã«ã¯ããããªãç ç©¶ãå¿ èŠã§ãã
ãã®çºè¡šäŒã«ã¯ãæ¿åºæ©é¢ãåœéæ©é¢ã倧åŠãç ç©¶æ©é¢ãå»çæ©é¢ãã130åã®åå è ãéãŸããŸãããç»å£è ã«ã¯ãäžåœç§åŠé¢é¢å£«ã®Chen Zhuæ°ãæž è¯å€§åŠå¯åŠé·ã®Wang Hongweiæ°ãåœå®¶çŸç äºé²ç®¡çå±å¯å±é·ã®Sun Yangæ°ãå»åŠèªãThe Lancetãç·šéé·ã®Richard Hortonæ°ããåãé£ããŸãããWHOäžåœä»£è¡šã®Martin Tayloræ°ã¯ããããªã¡ãã»ãŒãžãéããŠæ¬ã€ãã³ãã§æšæ¶ããŸããã
Hortonæ°ã¯ãå¥åº·ãšãæ é€ãæ°Žãäœå® ãæè²ãšãã£ã瀟äŒç決å®èŠå ãšã®é¢é£æ§ã«ã€ããŠè«ããŸãããChen Zhuæ°ã¯ãé©åãªå»çæè¡ããã©ã€ããªã±ã¢ã®çŸå Žã«æ®åãããããšããªãã³ã«äºé²ãã¹ã¯ãªãŒãã³ã°ãæ²»çãé·æçãªå¥åº·ç®¡çã®éã§ããç·å¯ãªé£æºãå³ãããšãåŒã³ãããŸãããäžåœå·¥çšé¢é¢å£«ã§å京倧åŠå»åŠéšäž»ä»»ã®Qiao Jieæ°ã¯ã女æ§ãšåã©ãã®å¥åº·ãå»çã®è³ªãæ£è ã®å°å³ã«ã€ããŠè¬æŒããŸãããUNICEFäžåœå¯ä»£è¡šã®Amanda Bissexæ°ã¯ãå¹Œå°æããã®å€æ¬¡å çè²§å°ãžã®å¯ŸåŠã«ãããŠãæ é€ãå»çã瀟äŒçæ¯æŽãæãã圹å²ã匷調ããŸããã
Margaret Chanæ°ã¯éäŒã®æšæ¶ã«ãããŠãå¥åº·ã®å ¬å¹³æ§ãšã¯ãã¹ãŠã®äººã ãèªãããå°éãããå¿ èŠãªãµãŒãã¹ãåããããããã«ããããšã ãšè¿°ã¹ãŸãããChanæ°ã¯ãæ¬å ±åæžã®çºè¡šã«ã€ããŠããããªãç ç©¶ãæ¿ç察話ãåœéååã®åºçºç¹ãšãªããã®ã§ãããšè¿°ã¹ãŸããã
ããããèšäº










ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã